
Jessica Marshall

Policy Issue Brief: A Call to Action for Diversity in Clinical Trials

A Global Early Warning System for Pandemics: A Blueprint for Coordination

Landscape of Trust: Health Data Frameworks

Models for Financing Antibiotic Development to Address Antimicrobial Resistance

Pandemic and All-Hazards Preparedness Act (PAHPA) Policy Brief

Milken Institute Outlines Next Steps for Mobilizing an Early Warning System for Pandemics

Milken Institute statement on ARPA-H inclusion in FY2022 spending bill

Comments on FDA’s Draft Guidance for Industry, Investigators, and Other Stakeholders on Decentralized Clinical Trials for Drugs, Biological Products, and Devices - Docket ID FDA-2022-D-2870
